Prevention And Treatment Of Synucleinopathic Disease

Patent No. EP1578253 (titled "Prevention And Treatment Of Synucleinopathic Disease") was filed by Elan Pharma on Oct 31, 2003. The application was issued on Sep 28, 2022.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
H LUNDBECKMay 18, 2016HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1578253

ELAN PHARMA
Application Number
EP03783083A
Filing Date
Oct 31, 2003
Status
Patent Maintained As Amended
Aug 26, 2022
Publication Date
Sep 28, 2022